Skip to main content
. 2021 Jun 12;22(8):1565–1573.e4. doi: 10.1016/j.jamda.2021.06.005

Supplementary Table 1.

Sensitivity Analyses of Incidence Rates and Incidence Rate Ratios for In-Hospital Death excluding 152 Patients Who Were Transferred to Other Departments or Hospitals

Admission Date Death (%) Model 1, IR, % (95% CI) Model 2, IR, % (95% CI) Model 1, IRR (95% CI) Model 2, IRR (95% CI) Model 3, IRR (95% CI)
March (n = 173) 54 (31.2) 31.0 (0.216, 0.338) 29.7 (0.209, 0.331) Ref Ref Ref
April (n = 669) 129 (19.3) 19.6 (0.153, 0.207) 18.8 (0.146, 0.196) 0.62 (0.45, 0.85) 0.68 (0.49, 0.95) 0.69 (0.49, 0.97)
May (n = 486) 52 (10.7) 10.5 (0.073, 0.122) 10.5 (0.076, 0.121) 0.30 (0.21, 0.45) 0.36 (0.24, 0.53) 0.37 (0.25, 0.56)
June (n = 244) 21 (8.6) 8.7 (0.046, 0.108) 8.3 (0.049, 0.104) 0.24 (0.15, 0.41) 0.31 (0.18, 0.52) 0.32 (0.19, 0.55)
July (n = 61) 2 (3.3) 3.6 (0.000, 0.080) 2.0 (0.012, 0.026) 0.11 (0.03, 0.46) 0.14 (0.03, 0.57) 0.14 (0.04, 0.59)
P trend <.001

Ref, referent.

Incidence rate (IR).

Model 1 standardized by age and sex.

Model 2 standardized by age and sex and vital signs [temperature, systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse rate, and saturation].

Incidence rate ratio (IRR): each admission month vs March.

Model 1 adjusted for age and sex and hospital.

Model 2 adjusted for age and sex and vital signs (temperature, SBP, DBP, pulse rate, and saturation) and hospital.

Model 3 adjusted for age and sex and vital signs (temperature, SBP, DBP, pulse rate and saturation), and medications [use of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), β-blocking agents, calcium channel blockers, diuretics, statins, low-molecular-weight heparin, non–vitamin K antagonist oral anticoagulants, warfarin, antiplatelets, nonsteroidal anti-inflammatory drugs, glucocorticoids, and antibiotics] and hospital.

P < .01.

P < .05.

P < .001.